OpenAlex
PricingAboutJobs
Log inGet started
Work

How molecular imaging is speeding up antiangiogenic drug development

HTML

Year: 2006
Type: review
Source: Molecular Cancer Therapeutics
DOI: 10.1158/1535-7163.mct-06-0395
Authors: Weibo Cai, Jianghong Rao, Sanjiv S. Gambhir, Xiaoyuan Chen
Institutions: Stanford Medicine, Stanford University
Language: English

Topic: Angiogenesis and VEGF in Cancer
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: molecular imaging, antiangiogenic drugs, tumor angiogenesis imaging, drug development, vascular endothelial growth factor, VEGF receptors, integrin αvβ3, matrix metalloproteinases, CD105, E-selectin, molecular probes, dose optimization
SDG: Good health and well-being

Open Access status: closed

Funders: National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering
Awards: Center of Cancer Nanotechnology Excellence Focused on Therapy Response, In Vivo Cellular and Molecular Imaging Center@Stanford, Imaging Alpha (v)beta(3) Integrin Expression, G3807723508, MicroPET and NIR Fluorescence Imaging Tumor Angiogenesis
OpenAlex ID: W2163830997
FWCI: 1.446
Cites: 87
Cited by: 180
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms